Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...
Last week, the FDA approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults. This approval will help offer additional aid for the many individuals throughout the world who live ...
CONNECTICUT (WTNH) — Rep. John Larson is thanking his supporters after he had a partial seizure Monday on the House floor, according to a press release from his team. On Tuesday night, Larson released ...
Please provide your email address to receive an email when new articles are posted on . The FDA recently approved XCOPRI for adults with partial-onset seizures, its manufacturer announced. “The ...
Vomiting 2.5 5.9 8.5 Vision blurred 2.5 2.2 8.5 Somnolence 4.7 5.2 8.1 Nasopharyngitis 5.8 6.3 7.6 Fatigue 5.8 7.0 7.2 Coordination abnormal 1.6 4.1 7.2 Tremor 4.1 3.7 6.2 Balance disorder 0.0 1.1 5.1 ...
The Food and Drug Administration on Wednesday approved Eisai’s epilepsy drug Fyompa as a primary treatment for partial-onset seizures in epileptic patients 12 years or older. Here are three things to ...
Research Triangle Park, NC (January 20, 2002) – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) granted marketing clearance for Lamictal® (lamotrigine) Tablets as ...
SK Life Science has announced the availability of Xcopri (cenobamate) tablets for the treatment of partial-onset seizures in adults.  SK Life Science has announced the availability of Xcopri ...
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic drug (AED) ...
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the antiepileptic lacosamide UCB (UCB Pharma SA) for partial-onset ...